Search - tctmd.com

Displaying 21 - 40 of 330

Sort: Relevancy | Date

News Daily News

Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival

L.A. McKeown

July 20, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Daily News

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Caitlin E. Cox

November 30, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

Yael L. Maxwell

November 03, 2022

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock

Caitlin E. Cox

April 18, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

Todd Neale

March 22, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Daily News

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

L.A. McKeown

September 07, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

Advertisement

Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

New Biomarker-Based Risk Score Performs Well in ACS

Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

No Stents in STEMI? With Careful Selection, Maybe

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

TCTMD’s Top 10 Most Popular Stories for November 2021

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content